|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/85 | |
| A01K 67/027 | |||
| C07K 16/46 | |||
| C07K 16/18 |
| (11) | Number of the document | 3128009 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16189625.3 |
| Date of filing the European patent application | 2012-09-18 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201116122 | 2011-09-19 | GB | |
| 201116120 | 2011-09-19 | GB | |
| 201203257 | 2012-02-24 | GB | |
| 201204592 | 2012-03-15 | GB | |
| 201205702 | 2012-03-29 | GB | |
| 201208749 | 2012-05-18 | GB | |
| 201211692 | 2012-07-02 | GB |
| (72) |
BRADLEY, Allan, GB
FRIEDRICH, Glenn A, GB
LEE, E-Chiang, GB
STRIVENS, Mark, GB
ENGLAND, Nicholas, GB
|
| (73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
| (54) | ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE |
| ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE |